Return to PJ Online Home Page
Hospital Pharmacist Vol 7 No 7 p178-182
July 2000 Special Features

Antibiotic resistance

Hospital acquired infection - the current situation

By P. T. Mannion, FRCPath, MSc

In the first part of our special feature on antibiotic resistance, the author discusses the measures already in place to control hospital acquired infection and suggests ways in which they can be made more effective
The second part of the feature covers restrictive antibiotic policies

Hospital infection control has become very topical in recent months due to three separate initiatives. First, the National Audit Office (NAO) report on infection control1 published earlier in the year. Second, the Controls Assurance Standards2 which has a section on hospital infection control, the baseline assessment for which had to be completed by March 31. The third initiative is the Department of Health (DoH) guidance HSC 2000/002, "The management and control of hospital infection"3 which is complimentary to the ideals and objectives of the controls assurance framework.
So what is a hospital acquired infection, or HAI? A generally accepted definition is that it is an infection acquired four days or more after admission to hospital.4 This may be considered somewhat artificial but at least it provides a basis for comparison. It is said that at any time nine per cent of hospital inpatients have a hospital acquired infection.1 Urinary tract infections and lower respiratory tract infections are the two commonest types of infection. This has obvious consequences in terms of increased mortality, morbidity, costs and length of stay.
A recently published study of HAI covered a 13-month period in one hospital in England.5 The project was funded by the Department of Health (DoH) and recruited 4,000 adult patients during the study period. Patients who experienced one or more HAIs incurred hospital costs that on average were 2.8 times greater than uninfected patients (an additional £2,917 per case) and they remained in hospital an average 2.5 times longer. Even after the adjustment for various factors (including age, diagnosis and the number of co-morbidities), patients with an HAI were 7.1 times more likely to die in hospital than uninfected patients. Extrapolation of these figures to the NHS in England produces an estimated cost of £986.36m annually for HAI (£930.62m while in hospital and £55.74m post-discharge). In terms of morbidity, patients who experience an HAI were estimated to need an additional 8.7m days nationally before they can resume normal daily activities.
There are clear guidelines for England and Wales as to how a typical hospital infection control service should be organised.6 The core of the service is the infection control team (ICT) comprising the trust infection control doctor (ICD) and one or more trust infection control nurses (ICNs). The ICD must have a sound knowledge of the management and control of infection in general as well as the specifics of hospital infection control. The ICD is normally a consultant medical microbiologist. Depending on the local circumstances, an infectious disease physician would also be a suitable choice. For the rest of this article I will assume the former model as it is the commoner of the two and one with which I am more familiar.
The ICD is generally an honorary title given to the individual acting on behalf of, and with, the authority of the chief executive of the trust (the latter is responsible for ensuring that there are effective arrangements for infection control). The title reflects the special interest and training of the ICD who would have obtained a CCST (certificate of completion of specialist training) in medical microbiology, usually after passing the relevant examination of the Royal College of Pathologists and becoming a member of the College (MRCPath). Nowadays, a more formal qualification in infection control can be sought.7
ICNs are specialist nurses who have to complete a one-year specialist training course before becoming independent practitioners. Traditionally, these have been diploma level courses although increasingly many ICNs continue their studies to BSc and ultimately MSc level (often in related subjects) while in post.
The ICDs and ICNs together perform the day-to-day duties of the ICT. The ICT cannot work in isolation and needs to be fully integrated into the trust with appropriate clerical, information technology (IT) and audit support from within the trust. Aside from responding to the day-to-day infection control problems of the trust, the ICT should ideally work to an annual programme developed by the trust infection control committee (ICC) of which the ICT is part. The ICT should produce regular updates or reports both to the ICC (which should meet at least twice a year) and to the trust management board or trust board on at least an annual basis. Guidance documents exist as to the composition of the ICC and the type of activities to be included in an annual programme.6 This has been reinforced by the controls assurance programme already referred to.
One could then ask that if hospitals have had ICTs and ICCs for many years (the first ICN was appointed in the UK in 1959), why do we still have problems with HAIs? It is certainly not due to a lack of effort on the part of ICTs/ICCs all over the country. Rather, it is related to the perception that infection control is a service provided for the trust when needed but not a primary responsibility of the clinical staff of the trusts. Most hospital clinical staff will be familiar with the ICT visiting the ward to advise on the care of individual patients with infections and will have been part of outbreak teams called upon to control a particular outbreak of infection (for example, Small round structured virus [SRSV]).
While clinical staff should be familiar with the infection control policies and guidance within their trust, as with any policy, they are only of benefit if they are clearly understood and regularly used. The NAO report and the other documents referred to at the start of this article are aiming towards changing the emphasis of the practice of infection control to one where clinicians confront the problems (for example, audit of wound infection rates, control of methicillin resistant Staphylococcus aureus, [MRSA]) while the ICT provided the specialist advice to guide them. It is a move that will place infection control within the clinical governance arena and not a stand-alone service provided for the trust. Infection control considerations need to be at the foundation of all activities within a trust.
Within hospitals, the health and safety officer and the ICT have been "risk managers" in their respective areas before this became a fashionable term. There is an overlap between the activities of the Health and Safety Committee (HSC) and the ICT/ICC, but there is also a difference in emphasis, with the ICT having a more clinical focus.
Generally, there is legislation on which all the Health and Safety Executive guidance is based and all organisations must comply with the current guidance. The guidance and policies that are available have been produced often by joint working groups (eg, "Revised guidelines for the control of methicillin resistant Staphylococcus aureus infection in hospitals"8) with representatives of the relevant societies and organisations such as the Public Health Laboratory Service (PHLS), Hospital Infection Society (HIS), Infection Control Nurses Association (ICNA) and the Association of Medical Microbiologists (AMM). It is interesting to note, however, that despite the problems caused by MRSA, no guidance on control and management within hospitals has ever been produced by the NHS.
Most of the DoH guidance relating to infection control is released by the NHS as health service circulars often in response to the findings of one of the national advisory groups. The recent circular "Variant Creutzfeldt-Jakob Disease (vCJD): minimising the risk of transmission"9 was released following the report of the Spongiform Encephalopathy Advisory Committee10 and is an example of such guidance. One of the biggest problems with this approach is that individual ICTs/ICCs then have to spend time developing local policies to implement such circulars and indeed one of the recommendations of the NAO report is that the DoH should consider producing a national infection control manual (with allowance for local "add-ons") as has been produced in Scotland.
Outside the trust, the local health authority (through its service agreements) will, in the future, monitor trusts to ensure that they meet the controls assurance standards on hospital acquired infection. Such external scrutiny has not been routine in the past. Approximately two years ago the DoH commissioned a group (EPIC) to produce a national infection control guidance. The first draft entitled "Draft evidence-based guidelines for preventing hospital acquired infections in England - indwelling urethral catheters" has recently been released on the internet for comment. This may well be the pattern for the future.
Unfortunately HAI will always occur but the aim of all hospitals should be to reduce this to the absolute minimum and the consensus from the NAO report is that a reduction of at least 15 per cent on current levels should be possible. So what are the problems with hospital infection control?

Resources

The Royal College of Pathologists recommends that the minimum input of an ICD should be three consultant sessions per 500 beds11 but additional sessions would be required, subject to the specialities present in the trust (transplant unit, renal unit, burns unit, etc). The NAO reported that most trusts fulfilled this guideline (Figure 1). In contrast, the accepted ratio for ICNs (based on American studies from the 1970s) is one full time ICN for every 250 hospital beds and the NAO report identified a huge variation in the trusts in England (Figure 2).
Figure 1
Figure 1: The ratio of infection control doctors to number of beds in 218 NHS trusts © UK National Audit Office
Figure 2
Figure 2: The ratio of whole time equivalent infection control nurses to number of beds in NHS trusts
Source for Figures 1 and 2: National Audit Office census, February 2000. © UK National Audit Office

Given the range of duties undertaken by the ICNs (including training, teaching and audit), either more time will need to be made available or clinical staff will have to take ownership of surveillance and audit to enable the ICN to have less of a hands-on role. Some trusts have link nurse schemes in place to try to act as a focus for infection control at ward level and although they can be successful at raising awareness, such schemes have encountered setbacks where there is a high staff turnover and where junior nurses take on the role but lack the authority to deal with more senior members of staff.
Another resource issue relates to how trusts fund the infection control service. Table 1 shows the breakdown of the budget elements that should be part of an infection control service. It can be seen that many trusts do not have all the elements formally budgeted for. Funding will obviously be found if infection-related problems occur but such an approach prevents a planned development of the infection control service to keep pace with the demands of the hospital.
Table 1: Items included in NHS trust infection control budgets
Budget elements recommended in DoH guidance* Number of trusts with item in budget % of trusts with item in budget**
Infection control doctor's time 17 20
Employment of infection control nurse(s) 76 89
Clerical and laboratory support staff costs 48 56
Microbiology tests and equipment specifically needed for infection control 18 21
Computer equipment for surveillance 25 29
Educational aids, videos, posters, etc 60 70
Training and education of infection control team members and provision of books, etc 63 74
Printing and dissemination of policies/manuals 45 53
Travel between institutions covered by infection control team 61 71
* The cost of managing outbreaks or other major infection incidents should be met from other sources such as contingency funds or insurance cover. If the infection control team provides infection control services outside the main hospital, these should be the subject of a clearly defined contract with associated funding (DoH 1995 guidance)
** There were 86 NHS trusts (40 per cent) with a separate budget for routine infection control
Source: National Audit Office census comparing actual contents against DoH 1995 guidance, February 2000. © UK National Audit Office

It is also relevant to note that the majority of infection control budgets have stayed the same between 1996 and 1999.1 Another common complaint of ICTs is insufficient clerical and IT support. It is also worthy of note that only 40 per cent of ICDs have access to their NHS trust patient information systems.1 This must become universal to ensure the "painless" collection of clinical data for HAI surveillance in the future.

Multi-resistant organisms

In the 1970s, multi-resistant Gram negative organisms (eg, Klebsiella spp, Enterobacter spp, and Serratia spp) were the main cause for concern but now Gram positive organisms are the problem, particularly the dreaded MRSA. Glycopeptide resistant enterococci (GRE, also termed vancomycin resistant enterococci [VRE]) and the most recently reported glycopeptide/vancomycin intermediate Staph aureus (GISA/VISA) which, despite its name, does not respond to glycopeptide antibiotics clinically are two more recently reported "problem" Gram positive organisms. Most consultant medical microbiologists (whether or not they are ICDs) are pivotal to the appropriate use of antibiotics in individual patients in their hospitals and, through their involvement with the trust drug and therapeutics committee, will be heavily involved with the production of the hospital antibiotic formulary.
MRSA is the commonest multi-resistant organism for most hospitals and its impact cannot be overemphasised, considering the range of infections that can be produced by Staph aureus or MRSA (Panel 1) and the fact that MRSA and Staph aureus were collectively the commonest causes of surgical site infection mentioned in a report that was recently published (Figure 3).12
Figure 3
Figure 3: Distribution of micro-organisms identified as causing surgical site infections for all categories of surgical procedures. Source: Surgical site infection, PHLS 1999 © PHLS

From an infection control perspective, the approach to all such resistant organisms is to prevent the spread to other patients, staff or visitors by the isolation of patients, reinforcement of good standards of hand hygiene and the use of appropriate personal protective equipment. This should be done in parallel with the appropriate and prompt treatment of the case. It is of significance in this respect that the NAO report noted that nearly a quarter of NHS trusts in England had seen a decrease in the number of isolation side-rooms between April, 1997, and March, 1998, and over 40 per cent of ICTs were either not very satisfied or not satisfied (in terms of the coded replies to the audit) with their current isolation facilities. Rates of MRSA must be monitored both to guide clinicians prescribing empirically for septic patients (they should consider the inclusion of a glycopeptide if MRSA is likely in that type of patient) and also to guide clinicians as to whether pre-admission or pre-operative screening of patients is of value.
A further consequence of the use of antibiotics in hospital are cases of antibiotic-associated diarrhoea due to Clostridium difficile. Control of this problem relates both to the approach to cases at ward level (with symptomatic cases usually being isolated) and an overall trust-wide approach to limit the use of antibiotics, in particular, cephalosporins. The pressures that all trusts experience due to the recent increases in emergency admissions to hospitals makes patient transfers between wards a common occurrence. This further increases the potential for spread of multi-resistant organisms.

Panel 1: Infections caused by Staphylococcus aureus

  • Skin and soft tissue infections:
    • impetigo
    • furuncles (boils)
    • carbuncles
    • abscesses
    • infected lacerations, post-operative wounds
    • folliculitis
    • IV line site infections
    • cellulitis
  • Urinary tract infection
  • Pneumonia (usually post-viral)
  • Arthritis
  • Osteomyelitis
  • Septicaemia
  • Bacterial endocarditis
  • "Staphylococcal scalded skin syndrome"
  • "Toxic shock syndrome"

Surveillance

Since the 1970s surveillance has been a key element of infection control in the United States and there is good evidence that with optimal infection control input, surveillance, combined with regular, planned feedback of data to clinicians can reduce hospital infection rates by up to 32 per cent.13
Most ICTs operate laboratory-based surveillance which is often based on the so-called "alert" organisms (Panel 2) but one of the key recommendations of the controls assurance standards for infection control is to widen the scope of surveillance to encompass more clinically-based surveillance (eg, post-operative wound infections). The DoH has sponsored the Nosocomial Infection National Surveillance Scheme (NINSS) to which all trusts can report. It was launched in March, 1996, and is currently run by the PHLS. A report of NINSS's analysis from 1997-98, and mentioned earlier in this article, was published recently.11 Trusts can enrol on the scheme for three-month modules and can nominate the category of surgical procedure to be looked at. Reports are then produced by the Nosocomial Infection Surveillance Unit (NISU) of the PHLS for the reporting trust and included is the anonymised data from other trusts for the same procedure. This allows trusts to compare their performance to others and also enables individual surgeons in a trust to compare their own performance with each other if they so wish.
Problems still remain in terms of surveillance of post-operative wound infections as it is estimated that 50 to 70 per cent of such infections occur after discharge (although a NINSS pilot is currently in progress on this). The current system is also very labour-intensive, taking up valuable ICN time to complete. The computer returns and report collation inevitably means that the data, when analysed, is three to six months old. In the future, the ideal scenario would be for each trust to have a system such as the NINSS to be part of the hospital patient information system so that all the relevant clinical data is constantly recorded in real time with local ownership and regular analysis of the data. The central reporting of this data would still be of importance to enable the national comparison of data as is currently provided by NISU. This could be the model for many types of clinical or laboratory-based surveillance schemes in the future.
Also critical to any surveillance system is that all centres use common definitions and criteria; otherwise comparison is meaningless. This is best exemplified by MRSA. The majority of patients who are found positive for MRSA have MRSA in wound swabs or on skin sites and mucous membranes of the body but do not show signs of infection. The MRSA is said to be colonising the patient. The number of "cases" of MRSA infection could be quite at variance, depending on whether one records all instances of MRSA colonisation or just those cases requiring treatment.

Panel 2: "Alert" organisms used in HAI surveillance

Streptococci, group A from wound and high vaginal swabs
Streptococci, group B from special care baby units and maternity departments
Staphylococcus aureus resistant to three or more antibiotics
Methicillin resistant Staph aureus
Gentamicin resistant micro-organisms
Shigella spp
Salmonella spp
Clostridium difficile
Clostridium perfringens
Mycobacterium tuberculosis
Hepatitis B virus (HBV)
Hepatitis A virus (HAV)
Hepatitis C virus (HCV)
Human immunodeficiency virus (HIV)
Meningitis (any cause, bacterial or viral)
Chickenpox (Herpes varicella)
Shingles (Herpes zoster)
Cryptosporidium
Escherichia coli 0157
Legionella
All other infectious agents causing notifiable infectious diseases or food poisoning not included in the list above

Training and education

This is a key function for ICTs. The majority of hospital staff with the exception of medical staff will receive an induction session that includes a basic awareness session of the principles of infection control. This obviously has to be tailored to the needs of staff attending the lecture. With medical staff, there is often a series of induction lectures when new house officers commence duties or change specialities, but unfortunately a consultant medical microbiologist or ICN has to compete for a 10 or 20 minute slot in an already crammed schedule. For senior medical staff, specialist registrars on regional rotations and locums there is often little or no opportunity to provide such induction sessions.
Updating and re-training nursing and medical staff once in post is a problem that, in my experience, has yet to be solved. The biggest problem is releasing staff to attend training sessions, When wards are busy or short-staffed it can be impossible for nursing staff to get away from the wards or have protected time. Medical staff have historically been able to take study leave; and continuous professional development (CPD) is an essential requirement for consultants both for re-accreditation and clinical governance. It would be of interest to find out from fellow consultants when they last attended an update session on infection control. It needs to become more of a core educational need for all medical staff, whether they are trained or in training.
An increased demand for training will have obvious consequences for manpower (increased ICN or ICD time will be required) but trusts are looking to utilise CD-ROM based self-teaching programmes which, if networked within a trust, can provide access at the workplace, particularly for staff who may have problems in attending daytime sessions, for example, night staff, agency staff, locum medical staff and members of professions allied to medicine.
The most important thing that all staff who care for patients must learn is to wash hands correctly. It sounds simplistic - everybody does it all the time. Interestingly, theatre scrub staff (medical and nursing) accept without question the need to be taught a surgical hand preparation but at the ward or clinic level health care staff do not clean their hands properly (Figure 4). Reinforcing the need for hand washing is part of the initial control measures in most hospital outbreaks but it is difficult to maintain the heightened awareness once an outbreak is over. Hand washing is critical to prevent the spread of infection and must follow every patient contact. It is of so much importance that the Handwashing Liaison Group produced an information leaflet for trust chief executives to suggest strategies to raise standards and improve awareness.14
Figure 4
Figure 4: Ineffective handwashing techniques result in some areas of the hands consistently being missed, facilitating cross infection by transient bacteria. Source: National Audit Office census, February, 2000. © UK National Audit Office

The safe use and disposal of "sharps" is also of critical importance. Sharps injuries can occur in many hospital settings. In operating theatres, the awareness about blood borne viruses (eg, human immunodeficiency virus and hepatitis C virus) has led to the introduction of many improved practices to prevent sharp instruments being passed from hand to hand and to avoid the use of sharps whenever possible. On the general wards and departments of any hospital, rigorous policies and procedures exist to ensure that all "sharps" are only disposed of in approved rigid containers (sharps' bins). Unfortunately, mistakes still occur and needles or other "sharps" can end up in the black domestic bin bags. The unfortunate consequence of such events can be a needle stick injury to innocent porters or domestic staff who have to handle such bags. All needle stick injuries must be taken seriously and any staff member must be offered appropriate post-exposure prophylaxis. Sharps injuries cause great concern to the injured party and it is the responsibility of all health care staff to ensure the safe disposal of any sharps they use in the care of patients.

Conclusion

The problems that ICTs face will always be challenging and will change due to the types of patients and the treatments being applied (for example, severely immunosuppressed patients). The current national focus on infection control will hopefully educate health care staff on their roles and responsibilities, because high standards of infection control mean high standards of patient care.
It is obvious that, at trust level, infection control has to take its place with all the other priorities. However, it cannot remain a Cinderella speciality and more resources may have to be committed to generate the long term improvements in standards we all hope to achieve. Infection control will become yet another tool by which health care standards are monitored and we must make the changes to ensure that HAI is reduced to the minimum to prevent the consequences for individual patients and to stop the wastage of valuable NHS resources. More awareness of such issues by patients and their relatives will also increase the pressure to raise standards further.

Dr Mannion is consultant medical microbiologist and hospital infection control doctor, based at the public health laboratory, Countess of Chester health park, Chester

References

1. National Audit Office. The management and control of hospital acquired infection in acute NHS trusts in England. London: Stationery Office; 2000.
2. Department of Health. Controls assurance guidelines supplementing HSC 1999/123. London: Department of Health; 1999.
3. NHS Executive. HSC 2000/002: The management and control of hospital infection. London: NHS Executive; 2000.
4. Glenister HM, Taylor LJ, Cooke EM, Bartlett CLR. A study of surveillance methods for detecting hospital infection. Public Health Laboratory Service; 1992.
5. Plowman R, Craves N, Griffin M, Roberts J, Swan A, Cookson B et al. The socio-economic burden of hospital acquired infection. London: Public Health Laboratory Service; 2000.
6. Department of Health. HSG (95)10: Hospital infection control: guidance on the control of infection in hospitals. London: Department of Health; 1995.
7. Emmerson AM, Spencer RC, Cookson BD, Roberts C, Drasar BS. Diploma in hospital infection control (Dip HIC). J Hosp Infect 1997;37:175-80.
8. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998;39:253-90.
9. Health and Safety Commission advisory committee on dangerous pathogens, spongiform encephalopathy advisory committee. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. London: Stationery Office; 1998.
10. NHS Executive. HSC 1999/178: Variant Creutzfeldt-Jakob disease (vCJD): minimising the risk of transmission. London: NHS Executive; 1999.
11. Royal College of Pathologists. Medical and scientific staffing of NHS pathology departments. London: The College; 1999.
12. Public Health Laboratory Service. Surgical site infection: analysis of a year's surveillance in English hospitals 1997-1998. London: Public Health Laboratory Service; 1999.
13. Haley RW, White JW, Culver DH, Meade Morgan W, Emori TG, Munn VP et al. The efficacy of infection surveillance and central programs in preventing nosocomial infections in US hospitals (SENIC). Am J Epidemiol 1985;121:182-205.
14. Handwashing Liaison Group. Hospital acquired infection: information for chief executives - why you need to be interested! London: Department of Health; 1999.